Isocarboxazid
Molecular Imaging
Imperial College LondonSmall moleculeEarly Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Molecular Imaging cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Idazoxan Imperial College London | Early Phase 1 | CC |
18F-MPG Harbin Medical University | N/A | D |
Same molecule, other indications
Isocarboxazid is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →